$10.690
+0.142 (+1.33%)Zum Schluss
HELP im Vergleich zur Peergroup
In the context of the broader market, HELP competes directly with industry leaders such as SILO and OGEN. With a market capitalization of $807.31M, it holds a leading position in the sector. When comparing efficiency, HELP's gross margin of N/A stands against SILO's -14.77% and OGEN's N/A. Such benchmarking helps identify whether Helus Pharma Inc. is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Cybin Inc
The company has reported continuous net losses, with Q4 2026 net income at -46,995,000 CAD and a forward P/E ratio of 0, indicating no earnings expected in the near term.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.